Kadmon Holdings, Inc. (KDMN) Financial Statements (2025 and earlier)
Company Profile
Business Address |
450 EAST 29TH STREET NEW YORK, NY 10016 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 281,309 | 305,967 | 134,422 | 159,701 | 182,295 | 148,240 | |||
Cash and cash equivalents | 61,881 | 132,018 | 74,423 | 105,949 | 169,803 | 120,046 | |||
Short-term investments | 219,428 | 173,949 | 59,999 | 53,752 | 12,492 | 28,194 | |||
Receivables | 1,543 | 1,519 | 695 | 373 | 396 | 1,234 | |||
Inventory, net of allowances, customer advances and progress billings | 12 | 22 | 102 | 28 | 116 | 500 | |||
Inventory | 12 | 22 | 102 | 28 | 116 | 500 | |||
Other undisclosed current assets | 3,894 | 3,197 | 2,082 | 2,240 | 2,639 | 2,854 | |||
Total current assets: | 286,758 | 310,705 | 137,301 | 162,342 | 185,446 | 152,828 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 14,504 | 15,204 | 16,112 | 17,013 | 17,902 | 18,782 | |||
Property, plant and equipment | 1,012 | 1,192 | 1,287 | 1,620 | 1,877 | 2,159 | |||
Long-term investments and receivables | 2,300 | ||||||||
Long-term investments | 2,300 | ||||||||
Intangible assets, net (including goodwill) | 3,580 | 3,580 | 3,580 | 3,580 | 3,580 | 3,580 | |||
Goodwill | 3,580 | 3,580 | 3,580 | 3,580 | 3,580 | 3,580 | |||
Restricted cash and investments | 2,117 | 2,117 | 2,117 | 2,117 | 2,117 | 2,117 | |||
Other noncurrent assets | 9 | 9 | 13 | 17 | 22 | 11 | |||
Other undisclosed noncurrent assets | 2,300 | 2,300 | 2,300 | 2,300 | 2,300 | ||||
Total noncurrent assets: | 23,522 | 24,402 | 25,409 | 26,647 | 27,798 | 28,949 | |||
TOTAL ASSETS: | 310,280 | 335,107 | 162,710 | 188,989 | 213,244 | 181,777 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 25,103 | 20,323 | 22,467 | 22,322 | 23,084 | 18,465 | |||
Accounts payable | 10,559 | 12,273 | 10,933 | 12,110 | 11,674 | 6,751 | |||
Accrued liabilities | 14,544 | 8,050 | 11,534 | 10,212 | 11,410 | 11,714 | |||
Debt | 2,718 | 1,699 | 4,822 | 5,436 | 4,024 | ||||
Derivative instruments and hedges, liabilities | 733 | 922 | 1,082 | 1,016 | 1,618 | 1,329 | |||
Other undisclosed current liabilities | 4,482 | 4,292 | 4,223 | ||||||
Total current liabilities: | 30,318 | 28,255 | 29,471 | 28,160 | 30,138 | 23,818 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 246,229 | 247,370 | 16,938 | 19,009 | 19,388 | 18,732 | |||
Long-term debt, excluding current maturities | 232,870 | 232,891 | 1,359 | 2,378 | 1,699 | ||||
Liabilities, other than long-term debt | 278 | 278 | 278 | 461 | 461 | 461 | |||
Deferred income tax liabilities | 278 | 278 | 278 | 461 | 461 | 461 | |||
Operating lease, liability | 13,359 | 14,479 | 15,579 | 16,631 | 17,689 | 18,732 | |||
Total noncurrent liabilities: | 246,507 | 247,648 | 17,216 | 19,470 | 19,849 | 19,193 | |||
Total liabilities: | 276,825 | 275,903 | 46,687 | 47,630 | 49,987 | 43,011 | |||
Equity | |||||||||
Equity, attributable to parent | 33,455 | 59,204 | 116,023 | 141,359 | 163,257 | 138,766 | |||
Preferred stock | 45,641 | 45,098 | 44,555 | 44,011 | 43,468 | 42,950 | |||
Common stock | 171 | 171 | 171 | 171 | 171 | 160 | |||
Additional paid in capital | 491,721 | 487,230 | 515,429 | 512,904 | 510,171 | 458,539 | |||
Accumulated other comprehensive loss | (165) | (270) | (28) | (25) | |||||
Accumulated deficit | (503,913) | (473,025) | (444,104) | (415,702) | (390,553) | (362,883) | |||
Equity, attributable to noncontrolling interest | |||||||||
Total equity: | 33,455 | 59,204 | 116,023 | 141,359 | 163,257 | 138,766 | |||
TOTAL LIABILITIES AND EQUITY: | 310,280 | 335,107 | 162,710 | 188,989 | 213,244 | 181,777 |
Income Statement (P&L) ($ in thousands)Annual | Quarterly
9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 197 | 563 | 615 | 490 | 448 | 6,735 | ||
Gain on disposition of assets for financial service operations | 4,274 | 15,510 | ||||||
Cost of revenue (Cost of Goods and Services Sold) | 203 | (148) | (622) | (284) | ||||
Other undisclosed gross profit | (11) | (96) | (446) | (214) | (162) | (328) | ||
Gross profit: | 186 | 467 | 372 | 128 | (336) | 6,123 | ||
Operating expenses | (32,181) | (27,870) | (31,611) | (28,133) | (26,584) | (22,240) | ||
Operating loss: | (31,995) | (27,403) | (31,239) | (28,005) | (26,920) | (16,117) | ||
Nonoperating income (expense) | 1,650 | (975) | 3,199 | 3,399 | (232) | (13,180) | ||
Investment income, nonoperating | 1,120 | 600 | 810 | (161) | 622 | |||
Gain on contract termination | 1,626 | |||||||
Other nonoperating income (expense) | (811) | 149 | (49) | 126 | 1 | |||
Interest and debt expense | (2,497) | (1,229) | 3,697 | (8) | (5) | |||
Loss from continuing operations before equity method investments, income taxes: | (32,842) | (29,607) | (24,343) | (24,614) | (27,157) | (29,297) | ||
Other undisclosed income (loss) from continuing operations before income taxes | 2,497 | 1,229 | (3,697) | 8 | 5 | |||
Loss from continuing operations before income taxes: | (30,345) | (28,378) | (28,040) | (24,606) | (27,152) | (29,297) | ||
Other undisclosed income from continuing operations | 182 | |||||||
Loss from continuing operations: | (30,345) | (28,378) | (27,858) | (24,606) | (27,152) | (29,297) | ||
Loss before gain (loss) on sale of properties: | (30,345) | (28,378) | (27,858) | (24,606) | (27,152) | (29,297) | ||
Net loss: | (30,345) | (28,378) | (27,858) | (24,606) | (27,152) | (29,297) | ||
Net loss attributable to noncontrolling interest | ||||||||
Other undisclosed net income attributable to parent | ||||||||
Net loss attributable to parent: | (30,345) | (28,378) | (27,858) | (24,606) | (27,152) | (29,297) | ||
Preferred stock dividends and other adjustments | (543) | (543) | (544) | (543) | (518) | (517) | ||
Other undisclosed net loss available to common stockholders, basic | ||||||||
Net loss available to common stockholders, diluted: | (30,888) | (28,921) | (28,402) | (25,149) | (27,670) | (29,814) |
Comprehensive Income ($ in thousands)Annual | Quarterly
9/30/2021 Q3 | 6/30/2021 Q2 | 3/31/2021 Q1 | 12/31/2020 Q4 | 9/30/2020 Q3 | 6/30/2020 Q2 | 3/31/2020 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (30,345) | (28,378) | (27,858) | (24,606) | (27,152) | (29,297) | ||
Other undisclosed comprehensive loss | (2,150) | |||||||
Comprehensive loss: | (30,345) | (28,378) | (30,008) | (24,606) | (27,152) | (29,297) | ||
Comprehensive loss, net of tax, attributable to noncontrolling interest | ||||||||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (438) | (785) | 1,603 | (568) | ||||
Comprehensive loss, net of tax, attributable to parent: | (30,783) | (29,163) | (28,405) | (25,174) | (27,152) | (29,297) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.